nicotinamide mononucleotide has been researched along with d-arg-dmt-lys-phe-nh2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eliasberg, CD; Rodeo, SA; Zhang, X | 1 |
| Bammler, TK; Bitto, A; Fredrickson, J; Imai, SI; Johnson, R; Latorre-Esteves, E; MacCoss, MJ; Rabinovitch, PS; Wang, L; Whitson, JA; Zhang, H | 1 |
1 review(s) available for nicotinamide mononucleotide and d-arg-dmt-lys-phe-nh2
| Article | Year |
|---|---|
Mitochondrial dysfunction and potential mitochondrial protectant treatments in tendinopathy.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Humans; Mice; Mitochondria; Nicotinamide Mononucleotide; Oligopeptides; Reactive Oxygen Species; Superoxide Dismutase; Tendinopathy; Tendons; Thiones | 2021 |
1 other study(ies) available for nicotinamide mononucleotide and d-arg-dmt-lys-phe-nh2
| Article | Year |
|---|---|
Age-related disruption of the proteome and acetylome in mouse hearts is associated with loss of function and attenuated by elamipretide (SS-31) and nicotinamide mononucleotide (NMN) treatment.
Topics: Animals; Mice; Mitochondria; Nicotinamide Mononucleotide; Oligopeptides; Proteome | 2022 |